Menu Menu

NRIX    Nurix Therapeutics Inc    1549595    
Income Statement
Revenue 12,588,000
Net Income -48,956,000
Profit Margin -388.91%

Balance Sheet
Current Assets 456,043,000
Assets 513,600,000
Current Liabilities 86,296,000
Liabilities 136,744,000
Equity 376,856,000
Shares Out 64,412,000

Cash Flow Statement
Operating Cash Flow -123,833,000
Investing Cash Flow -116,896,000

Market Analysis
Market Cap 1,603,855,040
Price 19.14
BVPS 5.85
PB 3.21
EPS -2.92
PS 31.85
FCF -240,729,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/15 -0.77
Apr May Jun
4/10 -0.76
Jul Aug Sep
7/11 -0.71
Oct Nov Dec
10/11 -0.67

Find a discrepancy? The most accurate way to find company fundamental data is to view NRIX documents filed with the SEC.


NRIX Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: